← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
D2g Oncology, Inc.
Palo Alto, CA
$1,999,557
Total funding
1
Grants
Funding over time
peak $1.1M · FY2020–21$2M$1.5M$1M$500K$0
'20
'21
Funding mix
By agency
NIH$1,999,557 · 1
By mechanism
R44$1,999,557 · 1
Investigators at D2g Oncology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform$1,134,487
R44 · FY2020 · CA
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform$865,070
R44 · FY2021 · CA